Get Started with NeoGenomics
IHC & ISH
NeoTYPE® Cancer Profiles
Cell-free circulating tumor DNA/RNA analysis on plasma to reduce the need for bone marrow biopsy procedures
NeoGenomics is pleased to introduce 14 new assays for the detection and measurement of critical biomarkers in the peripheral blood plasma of patients with known and suspected hematologic cancers. Cell-free circulating hematologic tumor nucleic acids can be analyzed in patients with bone marrow disease. Our scientists and others pioneered this work in hematologic disease over the past 10+ years, and now it is available for clinical use through a simple blood draw and routine shipping to our licensed, accredited molecular laboratory.
NeoLAB™ Liquid Biopsy plasma-based tests are available in four multiplex profiles and 10 single-gene analyses.
ASXL1, BRAF, CEBPA, DNMT3A, ETV6, FLT3, HRAS, IDH1, IDH2, JAK2 V617F, JAK2 Exon 12+14, KRAS, MLL, NPM1, NRAS, PDGFRA, PHF6, PTPN11, RUNX1, SETBP1, TET2, TP53 and WT
ASXL1, BCOR, BCORL1, BRAF, CBL, CEBPA, DNMT3A, ETV6, EZH2, FLT3, HRAS, IDH1, IDH2, JAK2 V617F, JAK2 Exon 12+14, KIT, KRAS, NPM1, NRAS, PDGFRA, PTEN, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2
ABL1, ASXL1, ATRX, BCOR, BCORL1, BRAF, CALR, CBL, CBLB, CBLC, CDKN2A, CEBPA, CSF3R, CUX1, DNMT3A, ETV6, EZH2, FBXW7, FLT3, GATA1, GATA2, GNAS, HRAS, IDH1, IDH2, IKZF1, JAK2 V617F, JAK2 Exon 12+14, JAK3, KDM6A, KIT, KRAS, MLL, MPL, MYD88, NOTCH1, NPM1, NRAS, PDGFRA, PHF6, PTEN, PTPN11, RAD21, RUNX1, SETBP1, SF3B1, SMC1A, SMC3, SRSF2, STAG2, TET2, TP53, U2AF1, WT1, ZRSR2
Use the buttons below to read more or to arrange a live phone call at your convenience with a NeoGenomics medical director.